The overexpression of miR-124, which functions as a tumor suppressor in BC, markedly inhibits the expression of angiogenesis markers including VEGF, MMP-2, and MMP-9, thereby suppressing the migration, invasion, and angiogenesis of BC cells in vitro, as well as tumor growth in vivo. This evidence concerns the gene VEGFA and breast cancer.